Bill115th CongressFiled Feb 28, 2018Health
S. 2476
Expanding Access to Low Cost Generic Drugs Act
Bill journey · stage 2 of 5
Under committee review
FiledFiled
CommitteeComm.
PassedFloor
Both ChambersBoth
Became LawLaw
What it doesSummary introduced in senate (Feb 28, 2018)
Expanding Access to Low Cost Generic Drugs Act
This bill amends the Federal Food, Drug, and Cosmetic Act to disqualify from receiving market exclusivity a generic drug manufacturer who enters into an agreement with the patent holder for a brand name drug to delay getting the generic drug approved or to delay marketing it.
What just happenedFeb 28, 2018
Read twice and referred to the Committee on Health, Education, Labor, and Pensions.
Who’s behind it
Sen. Smith, Tina [D-MN](D-MN)Sponsor
1committees2actions3related bills5subjects
- Introduced in SenateFeb 28, 2018
- Feb 28, 2018IntroReferral
Read twice and referred to the Committee on Health, Education, Labor, and Pensions.
Health, Education, Labor, and Pensions Committee - Feb 28, 2018IntroReferral10000
Introduced in Senate